MedTrace Logo

Virtual Reality During Exercise Testing

NCT06464406 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-06-21

No results posted yet for this study

Summary

The goal of this clinical trial is to explore the effects of virtual reality use on maximal aerobic exercise test performance (aerobic capacity) in healthy adults. The main questions it aims to answer are:

* Does using a virtual reality program during a maximal aerobic exercise test lead to differences in VO2peak (maximal aerobic capacity)? and,
* Does using a virtual reality program during a maximal aerobic exercise test lead to differences in work rate at the ventilatory threshold?

Participants will complete a maximal aerobic exercise test two times (separated by 1 week of recovery) under the following conditions:

* normal testing conditions in a lab
* while viewing a virtual reality video

Researchers will compare the test results of both conditions to see if the use of a virtual reality program alters VO2peak or the ventilatory threshold.

Conditions

  • Virtual Reality

Interventions

BEHAVIORAL

Virtual Reality condition

Participants will watch a video on a virtual reality headset during the completion of the maximal cardiorespiratory exercise test.

BEHAVIORAL

Control condition

Participants will complete the maximal cardiorespiratory exercise test under control conditions without video, music, or other distractions.

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Principal Investigators

  • Andrew R Moore, PhD · Augusta University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-07
Primary Completion
2024-10-07
Completion
2024-10-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06464406 on ClinicalTrials.gov